This paper addresses the potential for using virulence factor-activity relationships (VFAR) to discover and detect emerging waterborne pathogens. Emerging pathogens present two challenges to drinking water safety. The first is to improve the predictive value of tests for novel organisms that have recently been identified as emerging waterborne health threats, but are not yet well characterized. There are potential applications for VFAR in meeting this challenge, most notably to distinguish pathogens from closely related nonpathogenic organisms that may also be present in water samples. The second challenge is to prospectively identify new organisms that
INTRODUCTION
The Institute of Medicine and the Centers for Disease Control classify infectious diseases as "emerging" if their incidence in humans has increased in the past two decades, or threatens to increase in the near future (http:// www.cdc.gov/ncidod/EID/about/background.htm). The term is sometimes applied to well-known diseases, such as malaria, which have resurged in parts of the world.
However, it is more often applied to new pathogens that evolve from animal pathogens (e.g. HIV), to known human infections that have spread to new geographic areas or populations (e.g. hepatitis E, West Nile virus) or to infections that have increased with the increased population of humans who are elderly, immunocompromised or otherwise susceptible to rare diseases (e.g. Mycobacterium avium complex, Legionnaire's disease).
When an infectious disease emerges, there is a need to rapidly characterize its biology, ecology and epidemiology.
There may also be a need for new methods to detect the pathogen in water and other sources of environmental exposure. The VFAR concept was developed in part to help meet these needs (Board on Environmental Studies & to help distinguish new pathogens from closely related nonpathogenic organisms that might be found in the same environmental samples.
The bipartite definition of emerging pathogens (recently increased incidence or threat of future increase) presents two challenges relevant to drinking water safety. The first is to rapidly develop and maximize the predictive value of methods for detecting recently emerged human pathogens in environmental samples. The second (and much more ambitious) goal is to prospectively identify new organisms that are not yet known to be health risks to local populations, but have the potential of becoming so. This paper explores the feasibility of applying VFAR to both goals.
DETECTION OF KNOWN EMERGING PATHOGENS IN DRINKING WATER
Virulence is the result of an evolved strategy for replicating on or within a host, leading to pathology. The pathology may result from infection of normally sterile sites in the host, because the mechanisms for subverting or avoiding host defenses cause host damage or because the mechanisms for transmission to new hosts cause host damage. Such strategies are hypothesized to be relatively rare among organisms that have not evolved in close contact with animal hosts. However, a number of known human pathogens exist primarily in the external environment.
There are reasons to believe that there are also currently unrecognized pathogens that reside primarily in the external environment, including drinking water.
This section focuses on applications for VFAR in improving the predictive value of methods used to detect known emerging pathogens in drinking water. In the context of drinking water safety, "predictive value" refers to the probability that a positive test for the presence of a known human pathogen corresponds to a true threat to human health (i.e. it predicts or explains an elevated incidence of disease among susceptible people who are exposed).
Virulence as a variable trait
Tests for microbial contaminants in water are mechanistically diverse, ranging from traditional microbial cultivation methods to sophisticated tests for molecular markers in environmental samples. A shared feature is that they correlate taxonomic identification with the risk of disease.
For example, a water supply that tests positive for
Cryptosporidium parvum is understood to present a risk of Cryptosporidosis.
The assumption is that all cells and strains of this pathogen have approximately equal potential to cause disease. This assumption breaks down when applied to pathogen species that are internally diverse with regard to virulence potential. Detection of non-virulent strains constitutes background "noise" that reduces the predictive value of pathogen detection.
In the case of many environmental pathogens such as (Faruque et al. 1998; Vital Brazil et al. 2002) .
Most genetic and genomic analyses are conducted on clinical isolates of environmental pathogens, which can be expected to possess full complements of virulence genes.
Environmental isolates are examined far less frequently, and are likely to exhibit greater diversity than clinical
isolates. This can be tested by using genomic approaches such as microarray-based whole-genome comparisons.
However, it is important to note that quantitative genomic diversity does not always correspond to diversity in the ability to cause disease. For many waterborne pathogens, the extent of phenotypic diversity with regard to virulence remains unknown. In some cases this can be investigated through the use of non-human disease models, which can quantify virulence-associated phenotypes such as the ability to invade and grow within host cells (Widmer et al. 1998; Ohkusu et al. 2004; Widmer 2004; Danelishvili et al. 2007) .
For those pathogens which are confirmed by phenotypic and genotypic investigations to be diverse with regard to the ability to cause disease, tests for known virulence markers can help to improve the positive predictive value of their detection in drinking water.
The challenge of host range Species within the complex share 99.9% sequence similarity and they share most known virulence-associated genes (Sreevatsan et al. 1997; Brosch et al. 2001 Brosch et al. , 2002 In theory, an ortholog that exhibits modest homology to a To address these challenges, realistic VFAR strategies must incorporate very large numbers of virulence factors in combination with statistical methods to discern consequential from non-consequential matches. In addition, the characterization of virulence factors will not by itself be sufficient for the application of VFAR to human health; "host range" factors must also be characterized. In some cases, host range may simply be a function of growth temperature range, a parameter that may be difficult to discern by genotypic analysis. An alternative approach, described in the next subsection, is to combine VFAR methods with traditional phylogenetic approaches. The combined approaches may offer predictive values that exceed the sums of their parts.
Combined approaches incorporating virulence factors and phylogeny
In some cases phylogenetic markers have been identified that segregate with virulence and host range. For example, the mobile genetic element IS901 is common in bird isolates of M. avium, but is almost never seen in isolates from humans and other large mammals (Kunze et al. 1992; Bono et al. 1995; Pavlik et al. 2000) . IS901 carries no genetic information other than that needed for its own transposition, so the relationship between this element and preference for bird hosts is likely to be a matter of phylogeny (i.e. the evolutionary lineage that co-evolved with birds happens to have acquired or retained the element, while that which co-evolved with humans did not True VFARs can be identified by using high-throughput mutational approaches such as signature tagged mutagenesis (Chiang et al. 1999 ) and transposon-site hybridization (Sassetti & Rubin 2003) . These methods use sequence tagging systems or microarrays to identify large numbers of random transposon insertion mutants that are unable to grow under specific conditions such as growth in animal models, but not under other conditions such as free-living laboratory cultures. Genes that are disrupted in such mutants are assumed to be specifically required for life in animal hosts (some such genes are true virulence factors, while others code for more general metabolic and catabolic functions that are used in host environments).
These approaches have mainly been applied to bacterial pathogens, including Legionella pneumophila (Edelstein et al. 1999) and Vibrio cholera (Merrell et al. 2002) .
In some cases, it is possible to directly screen transposon mutant libraries for mutants that fail to exhibit virulence-associated properties that are visible during freeliving growth in the laboratory. For example, MAC grown on agar plates forms multiple colony types that vary with regard to virulence. Mutagenesis of "white" colony type variants, which are virulent and multi-drug-resistant, has yielded a large number of mutants that form "red" colonies, which normally are non-virulent. Some of these factors were subsequently shown to be required for virulence in disease models (Philalay et al. 2004; Cangelosi et al. 2006 ).
An alternative strategy is to identify genes that are differentially expressed, if not necessarily required, during growth in or on host cells. There are many ways to identify differentially expressed genes; examples that have been applied to waterborne and environmental pathogens include promoter probing (Rankin et al. 2002) , differential display (Schroeder et al. 1999) , selective capture of transcribed sequences (SCOTS) (Hou et al. 2002) and
in vivo induced antigen technologies (IVIAT) (Rollins et al. 2008) . Others have identified genes that are upregulated during growth in macrophages (Li et al. 2005) .
Subsequent mutational and comparative analyses often
result in the positive identification of virulence factors.
The research methods used to identify virulence factors in emerging pathogens may eventually be applied to the question of host range. For example, it has been observed that IS901-positive strains of M. avium isolated from birds express a protein, p40, which is not expressed in other phylogenetic clades of MAC, including human isolates of M. avium (Inglis et al. 2001) . Interestingly, the genetic information for p40 is present in almost all mycobacterial pathogens, but its high-level expression is seen only in bird isolates of MAC. In a separate microarray-based study, Bermudez and colleagues identified several putative virulence genes, including a putative pathogenicity island, that occur variably in Mycobacterium species with different host ranges (Harriff et al. 2008) . Expansion of such analyses may help to identify factors that are potentially useful as "host range factor -activity relationship" markers.
Conclusions: use of VFAR to improve the predictive value of detecting known emerging pathogens in drinking water
Virulence is a variable trait within many pathogen species.
Detection of non-virulent strains compromises the predic- to cope with these pressures can have multiple uses. For example, the formation of biofilms is an ecological strategy that improves microbial persistence in many habitats (Costerton et al. 1999; Donlan 2001 (Krzywinska & Schorey 2003; Krzywinska et al. 2005) .
However, they are also required for biofilm formation and planktonic dispersal of the pathogen in water habitats . Thus, the presence of ssGPL genes is not by itself evidence of a pathogenic lifestyle.
Many microbial factors important to human disease are adaptations to living within protozoal or animal hosts.
Legionella pneumophila, for example, lives within phagocytic environmental amoebae, an adaptation that may have enabled it to adapt to life within the professional phagocytic cells of humans (Swanson & Hammer 2000; Gal-Mor & Segal 2003) . The same may be true of MAC (Cirillo et al. 1997; Steinert et al. 1998; Miltner & Bermudez 2000) . Vibrio, Aeromonas and Pseudomonas species colonize the surfaces of zooplankton using bacterial factors that also contribute to colonization of the human tissues (Dumontet et al. 1996; Colwell et al. 2003; Pruzzo et al. 2003) . As with biofilm formation genes, these factors are widespread in the environment and far from specific to human pathogens.
An additional source of background already discussed is strains and species that infect animals but not humans. 
Additional challenges
In applying VFAR to the predictive identification of new human pathogens, a "positive result" would be the accurate 
